Europe Ultrasound Device Market is expected to reach US$ 4.77 billion by 2034 from US$ 2.93 billion in 2025, with a CAGR of 5.56% from 2026 to 2034. Third-party analysts indicated that the Europe ultrasound device market had experienced steady growth, driven by rising diagnostic demand, technological advancements, and expanding clinical applications across healthcare systems.
In addition, the market had been influenced by the growing burden of chronic diseases and age-related conditions across Europe, which had increased the demand for frequent diagnostic imaging. Ultrasound devices had been widely used in cardiology, obstetrics, gynecology, urology, and musculoskeletal imaging, among others. The shift toward point-of-care diagnostics had also strengthened the adoption of compact and handheld ultrasound systems, enabling faster clinical decision-making. Healthcare providers had increasingly prioritized efficiency and patient-centric care, which had further encouraged the integration of advanced ultrasound technologies into both primary and specialized care settings.
Furthermore, continuous innovation by medical device manufacturers had shaped competitive dynamics within the region. The industry had seen ongoing improvements in software integration, artificial intelligence-based imaging support, and enhanced workflow automation. These developments had contributed to improved diagnostic precision and reduced operator dependency. At the same time, healthcare digitization initiatives across European countries had supported the adoption of connected imaging systems. Overall, the Europe ultrasound device industry had evolved into a technologically advanced and widely adopted segment of the medical imaging market, with sustained focus on innovation, accessibility, and improved patient outcomes.
Despite these improvements, a 2024 thorough review found that several commercial algorithms show domain shift when used outside of the training institution, highlighting the significance of multi-center validation. The majority of adaptive algorithms are now categorized by the EU MDR as high-risk software, which requires the submission of prospective clinical evidence and lengthens the time it takes for a device to be approved. In order to expedite approval once those datasets are made accessible, the European Society of Radiology is creating common evaluation measures.
Europe Ultrasound Device Industry Overview
The Europe ultrasound device industry had been characterized by steady expansion, supported by increasing reliance on non-invasive diagnostic imaging across healthcare systems. Third-party assessments had indicated that ultrasound technology had remained a preferred imaging modality due to its safety profile, cost-effectiveness, and wide clinical applicability. Hospitals, diagnostic centers, and ambulatory care settings had increasingly integrated ultrasound systems into routine clinical workflows. The adoption had been further influenced by growing awareness of early disease detection and preventive healthcare practices. Technological advancements had played a key role in shaping the industry landscape, with improvements in image clarity, portability, and real-time imaging capabilities enhancing diagnostic accuracy and usability across multiple medical disciplines.In addition, the market had been influenced by the growing burden of chronic diseases and age-related conditions across Europe, which had increased the demand for frequent diagnostic imaging. Ultrasound devices had been widely used in cardiology, obstetrics, gynecology, urology, and musculoskeletal imaging, among others. The shift toward point-of-care diagnostics had also strengthened the adoption of compact and handheld ultrasound systems, enabling faster clinical decision-making. Healthcare providers had increasingly prioritized efficiency and patient-centric care, which had further encouraged the integration of advanced ultrasound technologies into both primary and specialized care settings.
Furthermore, continuous innovation by medical device manufacturers had shaped competitive dynamics within the region. The industry had seen ongoing improvements in software integration, artificial intelligence-based imaging support, and enhanced workflow automation. These developments had contributed to improved diagnostic precision and reduced operator dependency. At the same time, healthcare digitization initiatives across European countries had supported the adoption of connected imaging systems. Overall, the Europe ultrasound device industry had evolved into a technologically advanced and widely adopted segment of the medical imaging market, with sustained focus on innovation, accessibility, and improved patient outcomes.
Growth Drivers for the Europe Ultrasound Device Market
Point-of-care Adoption and Miniaturization in Home Care and Ambulances
Before patients arrive at emergency rooms, paramedics can evaluate internal bleeding or cardiac function using handheld probes that cost less than $5,000, like the Butterfly iQ3 and GE HealthCare Vscan Air SL. These probes provide high-quality pictures straight to cellphones. Clarius devices help home nursing teams who require quick deep vein or bladder scans by adding AI auto-measurements and direct DICOM output over Wi-Fi. In 2025, the UK released 54 ultrasound procurement notifications, with a large portion going for portable equipment for its community hubs. However, because many insurers only reimburse handheld scans at 50-70% of cart exam rates or not at all, payment gaps continue to exist and discourage use in smaller practices. Vendors can overcome regulatory obstacles by adhering to ISO 13485 and IEC 60601 standards; nevertheless, widespread acceptance depends on updated fee schedules.Exam Time Reduction using AI-Enabled Workflow Efficiencies
By automating labor-intensive metrics like ejection fraction and fetal biometry, cart systems like Samsung Medison HERA W10 Elite and Philips EPIQ Elite reduce the sonographer's burden by about 25% every session. Clinicians can now describe fibrosis in fewer sweeps according to Siemens Healthineers' latest ACUSON Sequoia, which uses deep learning in liver elastography.Despite these improvements, a 2024 thorough review found that several commercial algorithms show domain shift when used outside of the training institution, highlighting the significance of multi-center validation. The majority of adaptive algorithms are now categorized by the EU MDR as high-risk software, which requires the submission of prospective clinical evidence and lengthens the time it takes for a device to be approved. In order to expedite approval once those datasets are made accessible, the European Society of Radiology is creating common evaluation measures.
Higher Use of Diagnostic Imaging in Primary Care
In order to reduce referral, wait times and handle non-urgent problems on-site, primary-care doctors around Western Europe are outfitting their offices with portable or laptop ultrasound equipment. Germany's general practice penetration rate is already 98%, making it a model for other health systems. By installing portable scanners in 155 Community Diagnostic Centers, the UK's Integrated Diagnostics and Pathology framework is reducing demand on radiology departments by enabling musculoskeletal and abdominal scans to be performed outside of hospitals. Because hospital-centric imaging is still favored by budgets and payment codes, Eastern Europe continues to lag behind. The rate at which adoption expands to that area will depend on whether ministries modify tariff schedules for primary-care scans.Challenges in the Europe Ultrasound Device Market
High cost of advanced ultrasound systems
One of the major challenges in the Europe ultrasound device market had been the high cost associated with advanced imaging systems. While basic ultrasound devices had been widely accessible, technologically advanced systems incorporating AI, 3D imaging, and enhanced software capabilities had required significant investment. This had created budget constraints, particularly for smaller healthcare facilities and clinics. Procurement and maintenance costs had also added to the financial burden. As a result, adoption of high-end ultrasound systems had sometimes been limited to well-funded hospitals and diagnostic centers. Additionally, reimbursement limitations in certain healthcare systems had further influenced purchasing decisions. These cost-related factors had acted as a restraint on broader market penetration of advanced ultrasound technologies.Shortage of skilled ultrasound operators
Another key challenge had been the shortage of trained and skilled ultrasound operators across several parts of Europe. Although ultrasound devices had become more user-friendly, accurate diagnosis had still depended significantly on operator expertise. Variations in training standards and experience levels had impacted imaging quality and diagnostic consistency. The increasing complexity of advanced ultrasound systems had further highlighted the need for specialized training. In some healthcare settings, this shortage had led to delays in diagnosis and underutilization of advanced features. Efforts to address this gap through training programs had been ongoing, but the demand for skilled professionals had continued to outpace supply in certain regions.France Ultrasound Device Market
The France ultrasound device market had been supported by a well-developed healthcare system and strong emphasis on diagnostic imaging. Ultrasound technology had been widely adopted across public and private healthcare facilities due to its safety and diagnostic efficiency. The country had witnessed increasing use of ultrasound in obstetrics, cardiology, and general imaging applications. Growing awareness of early disease detection and preventive healthcare had further supported adoption. Additionally, technological advancements had encouraged the integration of modern ultrasound systems in hospitals and diagnostic centers. The shift toward outpatient care and point-of-care diagnostics had also contributed to increased usage of portable ultrasound devices. Healthcare infrastructure modernization initiatives had further strengthened demand for advanced imaging systems. Overall, the market had continued to evolve with a focus on improving diagnostic accuracy and patient care efficiency.Germany Ultrasound Device Market
The Germany ultrasound device market had been characterized by strong technological adoption and a highly structured healthcare system. Ultrasound devices had been widely used across hospitals, specialty clinics, and diagnostic centers. The country had placed significant emphasis on high-quality imaging and diagnostic precision, which had driven the adoption of advanced ultrasound systems. Applications in cardiology, oncology, and musculoskeletal imaging had been particularly prominent. Increasing demand for minimally invasive diagnostic procedures had further supported market growth. Germany’s strong medical technology sector had also encouraged continuous innovation in ultrasound equipment. Integration of digital health solutions and AI-based imaging tools had enhanced diagnostic workflows. Additionally, the expansion of outpatient care services had supported the use of portable and point-of-care ultrasound devices. The market had remained highly competitive, with a strong focus on quality and innovation.Italy Ultrasound Device Market
The Italy ultrasound device market had been influenced by increasing demand for diagnostic imaging and ongoing healthcare modernization efforts. Ultrasound systems had been widely used in public hospitals and private diagnostic centers, particularly in obstetrics, cardiology, and abdominal imaging. The growing burden of chronic diseases had further increased reliance on imaging technologies for early diagnosis and monitoring. Adoption of portable ultrasound devices had also been rising, especially in outpatient and emergency care settings. Technological advancements had supported improved imaging quality and operational efficiency. Additionally, healthcare system reforms and investments in medical infrastructure had contributed to market development. Despite budget constraints in certain regions, demand for cost-effective and reliable diagnostic tools had remained strong. The market had continued to evolve with a focus on accessibility and improved patient outcomes.Spain Ultrasound Device Market
The Spain ultrasound device market had been driven by increasing adoption of advanced diagnostic imaging solutions across healthcare facilities. Ultrasound technology had been widely utilized due to its non-invasive nature and cost-effectiveness. Applications in gynecology, cardiology, and general imaging had been particularly significant. The growing focus on early diagnosis and preventive healthcare had supported consistent demand for ultrasound systems. Healthcare infrastructure improvements and digital transformation initiatives had further strengthened adoption. Portable and point-of-care ultrasound devices had gained popularity in emergency and outpatient settings. Additionally, rising awareness among healthcare professionals regarding advanced imaging techniques had contributed to market growth. Although budget limitations in certain healthcare segments had posed challenges, the demand for efficient diagnostic tools had remained steady. The market had continued to progress with increasing emphasis on accessibility and technological advancement.Recent Developments in Europe Ultrasound Device Market
- In In October 2025, GE HealthCare unveiled Voluson Performance 18 and 16, which added AI automation to increase productivity in women's health.
- GE HealthCare introduced the Vivid Pioneer cardiovascular console in August 2025; promising cardiologists faster frame rates and automatic quantification.
- In March 2025, FUJIFILM expanded their minimally invasive toolset by introducing the EG-740UT interventional ultrasonic endoscope throughout Europe.
- September 2024: Butterfly Network doubled processing speed over previous generations and strengthened its European presence with the CE marking of the iQ3 handheld probe.
Europe Ultrasound Device Market Segments
Application
- Anesthesiology
- Cardiology
- Gynecology/Obstetrics
- Musculoskeletal
- Vascular
- Other
Technology
- 2D Ultrasound Imaging
- 3D and 4D Ultrasound Imaging
- Doppler Imaging
- High-intensity Focused Ultrasound
Type
- Stationary Ultrasound
- Portable Ultrasound
End User
- Hospitals
- Diagnostic Centers
- Other End Users
Country
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherlands
- Russia
- Poland
- Greece
- Norway
- Romania
- Portugal
- Row of Europe
All companies have been covered with 5 Viewpoints
- Overviews
- Key Person
- Recent Developments
- SWOT Analysis
- Revenue Analysis
Company Analysis
- Fujifilm Holdings Corporation
- GE Healthcare
- Hitachi Medical Corporation
- Philips Healthcare
- Samsung
- Siemens Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
Table of Contents
1. Introduction3. Executive Summary5. Europe Ultrasound Device Market12. Merger and Acquisition
2. Research & Methodology
4. Market Dynamics
6. Market Share Analysis
7. Application - Historical and Current Market Trends & Forecast
8. Technology - Historical and Current Market Trends & Forecast
9. Types - Historical and Current Market Trends & Forecast
10. End User - Historical and Current Market Trends & Forecast
11. Country - Historical and Current Market Trends & Forecast
13. Porter's Five Forces Analysis
14. SWOT Analysis
15. Key Players Analysis
Companies Mentioned
- Fujifilm Holdings Corporation
- GE Healthcare
- Hitachi Medical Corporation
- Philips Healthcare
- Samsung
- Siemens Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | June 2026 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 2.93 Billion |
| Forecasted Market Value ( USD | $ 4.77 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Europe |
| No. of Companies Mentioned | 8 |
